CDC calls for fit-tested N95 respirators to counter spread of H1N1
This article was originally published in The Gray Sheet
Executive Summary
Centers for Disease Control and Prevention issues new personal protective equipment recommendations advising workers in close contact with H1N1 influenza cases to wear fit-tested, N95 respirators to avoid spreading the virus. Previous CDC infection control guidance for seasonal influenza advised use of surgical masks. The agency's more conservative approach for H1N1 is in line with a Sept. 3 Institute of Medicine report saying that it is still not known if the H1N1 virus spreads through personal contact, droplet spray or airborne transmission. At an August IoM meeting, researchers shared findings on the effectiveness of personal protective equipment ("1The Gray Sheet" Aug. 24, 2009)
You may also be interested in...
N95 respirators for H1N1 protection
The American Hospital Association in a Sept. 15 letter requests that the Centers for Disease Control and Prevention reconsider its recommendations that health care workers caring for H1N1 influenza victims wear fit-tested N95 respirators, "given the limited supply of N95 respirators." To date, the virus "has not changed to become more severe" than seasonal influenza, AHA says. CDC issued the call for fit-tested N95 respirators earlier this month as a precaution, because it is still unknown if the H1N1 virus spreads through personal contact, droplet spray or airborne transmission ("1The Gray Sheet" Sept. 14, 2009)
Feds Seeking A Few Good Tests, And Masks, For Flu Season
With an especially challenging flu season expected this year, government officials are scrambling to evaluate the tools they have available to monitor, diagnose and limit spread of the virus
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.